According to Zacks, “American Vanguard Corporation is a diversified specialty and agricultural products company focusing on crop protection, turf and ornamental markets, and public health applications. The Company has continued its successful strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. Through skilful marketing, diligent product registration, quality manufacturing, American Vanguard has positioned itself to capitalize on developing trends in modern agriculture. American Vanguard continues to meet the needs of a world demanding ever-increasing quantities of agricultural products for human food, animal feed, natural fibers and alternative fuels. “
Separately, ValuEngine raised American Vanguard from a sell rating to a hold rating in a report on Tuesday, September 10th.
American Vanguard (NYSE:AVD) last issued its earnings results on Tuesday, August 6th. The basic materials company reported $0.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.02. The company had revenue of $113.10 million during the quarter, compared to the consensus estimate of $109.83 million. American Vanguard had a return on equity of 6.34% and a net margin of 4.60%. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.19 EPS. On average, equities research analysts anticipate that American Vanguard will post 0.68 EPS for the current fiscal year.
The company also recently declared a — dividend, which will be paid on Thursday, October 17th. Investors of record on Thursday, October 3rd will be issued a dividend of $0.02 per share. The ex-dividend date is Wednesday, October 2nd. This represents a yield of 0.5%. American Vanguard’s payout ratio is currently 9.88%.
In other news, CEO Eric G. Wintemute purchased 5,000 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The stock was acquired at an average cost of $14.08 per share, with a total value of $70,400.00. Following the acquisition, the chief executive officer now owns 955,060 shares in the company, valued at approximately $13,447,244.80. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Ulrich Trogele purchased 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were purchased at an average cost of $14.24 per share, with a total value of $28,480.00. Following the completion of the acquisition, the chief operating officer now owns 126,201 shares in the company, valued at approximately $1,797,102.24. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 7,700 shares of company stock valued at $109,050. 5.30% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in American Vanguard by 65.5% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,943 shares of the basic materials company’s stock valued at $45,000 after acquiring an additional 1,165 shares in the last quarter. Aperio Group LLC acquired a new position in American Vanguard in the 2nd quarter valued at $116,000. Cubist Systematic Strategies LLC acquired a new position in American Vanguard in the 2nd quarter valued at $150,000. JPMorgan Chase & Co. raised its holdings in American Vanguard by 16.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 10,913 shares of the basic materials company’s stock valued at $164,000 after acquiring an additional 1,529 shares in the last quarter. Finally, Paloma Partners Management Co acquired a new position in American Vanguard in the 2nd quarter valued at $180,000. 75.76% of the stock is owned by hedge funds and other institutional investors.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Recommended Story: Different Types of Derivatives
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.